Cargando…
Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear-cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial...
Autores principales: | Yang, Lin, Yu, Shi-Ying, Hu, Guang-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845622/ https://www.ncbi.nlm.nih.gov/pubmed/23237217 http://dx.doi.org/10.5732/cjc.012.10184 |
Ejemplares similares
-
Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
por: Kim, Seok Bae
Publicado: (2021) -
Pituitary metastasis from renal cell carcinoma presenting with significant hyperprolactinemia, case report
por: Mazar‐Atabaki, Ali, et al.
Publicado: (2023) -
Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021) -
Pituitary metastasis as the first manifestation of lung carcinoma
por: Amaral, Sara, et al.
Publicado: (2022) -
Successful treatment with sorafenib for sunitinib‐refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib
por: Morinaga, Ryota, et al.
Publicado: (2018)